142 related articles for article (PubMed ID: 27363016)
1. Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus.
Dai L; Bai L; Lin Z; Qiao J; Yang L; Flemington EK; Zabaleta J; Qin Z
Oncotarget; 2016 Jul; 7(30):47052-47060. PubMed ID: 27363016
[TBL] [Abstract][Full Text] [Related]
2. Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts.
Dai L; Qin Z; Defee M; Toole BP; Kirkwood KL; Parsons C
Cancer Lett; 2012 May; 318(2):214-20. PubMed ID: 22186301
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
[TBL] [Abstract][Full Text] [Related]
4. Kaposi Sarcoma-Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation.
Dai L; Qiao J; Yin J; Goldstein A; Lin HY; Post SR; Qin Z
J Infect Dis; 2020 Mar; 221(8):1331-1341. PubMed ID: 31111897
[TBL] [Abstract][Full Text] [Related]
5. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.
Botto S; Totonchy JE; Gustin JK; Moses AV
mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
7. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
[TBL] [Abstract][Full Text] [Related]
10. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
Li Y; Zhong C; Liu D; Yu W; Chen W; Wang Y; Shi S; Yuan Y
Cancer Res; 2018 Jan; 78(1):230-245. PubMed ID: 29066510
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Wen KW; Damania B
Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
[TBL] [Abstract][Full Text] [Related]
12. Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter.
Rose TM; Bruce AG; Barcy S; Fitzgibbon M; Matsumoto LR; Ikoma M; Casper C; Orem J; Phipps W
PLoS Pathog; 2018 Dec; 14(12):e1007441. PubMed ID: 30557332
[TBL] [Abstract][Full Text] [Related]
13. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.
Tan X; Gao Y; Nan Y; Zhang J; Di C; Wang X; Lian F; Cao Y; Hu Y; Xu L; Ma H; Hong Y; Liu T; Wu Y; Xu X; Yan Y; Yang L
PLoS One; 2015; 10(7):e0132148. PubMed ID: 26197270
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
15. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
16. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
18. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.
Grundhoff A; Ganem D
J Clin Invest; 2004 Jan; 113(1):124-36. PubMed ID: 14702116
[TBL] [Abstract][Full Text] [Related]
19. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
20. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.
Dai L; Chen Y; Bonstaff K; Doyle L; Toole B; Parsons C; Qin Z
Cancer Lett; 2015 Jul; 362(2):158-66. PubMed ID: 25837851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
